Related references
Note: Only part of the references are listed.Naturally Engineered Maturation of Cardiomyocytes
Gaetano J. Scuderi et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2017)
Anthracycline Chemotherapy and Cardiotoxicity
John V. McGowan et al.
CARDIOVASCULAR DRUGS AND THERAPY (2017)
Management Strategies and Outcomes for Very Elderly Patients With Diffuse Large B-Cell Lymphoma
Dai Chihara et al.
CANCER (2016)
Pharmacokinetic and pharmacodynamic study of doxorubicin in children with cancer: results of a European Pediatric Oncology Off-patents Medicines Consortium trial
Miriam Krischke et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity
Paul W. Burridge et al.
NATURE MEDICINE (2016)
Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States
Chadi Nabhan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Human pluripotent stem cell-derived cardiomyocytes: Genome-wide expression profiling of long-term in vitro maturation in comparison to human heart tissue
Ilaria Piccini et al.
GENOMICS DATA (2015)
Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium
Philip T. Sager et al.
AMERICAN HEART JOURNAL (2014)
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
Yoshihiko Ichikawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Chemically defined generation of human cardiomyocytes
Paul W. Burridge et al.
NATURE METHODS (2014)
Human Stem Cells for Modeling Heart Disease and for Drug Discovery
Elena Matsa et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Ultrastructural Maturation of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Long-Term Culture
Tsukasa Kamakura et al.
CIRCULATION JOURNAL (2013)
Downregulation of doxorubicin-induced myocardial apoptosis accompanies postnatal heart maturation
Jianjian Shi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
Decline in the Use of Anthracyclines for Breast Cancer
Sharon H. Giordano et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Sui Zhang et al.
NATURE MEDICINE (2012)
Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials
Lesley A. Smith et al.
BMC CANCER (2010)
American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants
Martee L. Hensley et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Differences in doxorubicin-induced apoptotic signaling in adult and immature cardiomyocytes
Eugene A. Konorev et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Adriamycin-induced oxidative mitochondrial cardiotoxicity
J. M. Berthiaume et al.
CELL BIOLOGY AND TOXICOLOGY (2007)
Reduced Apaf-1 levels in cardiomyocytes engage strict regulation of apoptosis by endogenous XIAP
MB Potts et al.
JOURNAL OF CELL BIOLOGY (2005)
Construction, characterization, and complementation of a conditional-lethal DNA topoisomerase IIα mutant human cell line
AJ Carpenter et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults
O Hequet et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Congestive heart failure in patients treated with doxorubicin - A retrospective analysis of three trials
SM Swain et al.
CANCER (2003)
Cellular roles of DNA topoisomerases: A molecular perspective
JC Wang
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children:: a systematic review
LCM Kremer et al.
ANNALS OF ONCOLOGY (2002)
Share Paper
